A unified language model bridging de novo and fragment-based 3D molecule design delivers potent CBL-B inhibitors for cancer treatment
Authors:
- Han WangHWHan Wang
- Guanglong SunGSGuanglong Sun
- Bowen ZhangBZBowen Zhang
- Yang WangYWYang Wang
- Bin XiBXBin Xi
- Minjian YangMYMinjian Yang
- Chuanyu LiuCLChuanyu Liu
- Yuyang GeYGYuyang Ge
- Fan FanFFFan Fan
- Wei FengWFWei Feng
- Yanhao ZhuYZYanhao Zhu
- Yang XiaoYXYang Xiao
Preprint
Abstract
The rational design of small molecules is central to drug discovery, yet current artificial intelligence (AI) methodologies for generating three-dimensional (3D) molecules are often siloed, focusing on either de novo design or fragment-based design. The lack of a holistic framework limits AI’s application across the complex and multi-step pipeline spanning from novel scaffold identification to lead compound optimization, and prevents AI from effectively learning from the entire process. Here, we introduce UniLingo3DMol, a language model for 3D molecular generation, empowered by fragment permutation-capable molecular representation alongside multi-stage and multi-task training strategy. This integrated design enables UniLingo3DMol to seamlessly span both de novo and fragment-retained molecular design, demonstrating superior performance over existing generation models in in silico evaluations across more than 100 diverse biological targets. We further leveraged UniLingo3DMol in the design of inhibitors targeting CBL-B, a crucial immune E3 ubiquitin ligase and attractive immunotherapy target. This strategy led to a lead compound demonstrating excellent in vitro activity and robust in vivo anti-tumor efficacy. Our findings establish UniLingo3DMol as a generalized and powerful platform, showing the strong potential to advance AI-driven drug discovery.Keywords
Funding Information
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z241100007724005)
This publication has 49 references indexed in Scilit:
- From part to whole: AI-driven progress in fragment-based drug discoveryCurrent Opinion in Structural Biology, 2025
- How Good are Current Pocket-Based 3D Generative Models?: The Benchmark Set and Evaluation of Protein Pocket-Based 3D Molecular Generative ModelsJournal of Chemical Information and Modeling, 2024
- Synergy and Complementarity between Focused Machine Learning and Physics-Based Simulation in Affinity PredictionJournal of Chemical Information and Modeling, 2021
- Structure-based molecular modeling in SAR analysis and lead optimizationComputational and Structural Biotechnology Journal, 2021
- A hierarchical approach to all‐atom protein loop predictionProteins: Structure, Function, and Bioinformatics, 2004
- On the Role of the Crystal Environment in Determining Protein Side-chain ConformationsJournal of Molecular Biology, 2002
- QSAR and 3D QSAR in drug design Part 2: applications and problemsDrug Discovery Today, 1997
- QSAR and 3D QSAR in drug design Part 1: methodologyDrug Discovery Today, 1997
- The Jensen-Shannon divergenceJournal of the Franklin Institute, 1997
- NMRPipe: A multidimensional spectral processing system based on UNIX pipesJournal of Biomolecular NMR, 1995